|
🐜
|
Integrative Clinical Genomics of Advanced Prostate Cancer
73 auth.
D. Robinson,
E. Allen,
Yi-Mi Wu,
N. Schultz,
R. Lonigro,
J. Mosquera,
B. Montgomery,
M. Taplin,
C. Pritchard,
G. Attard,
H. Beltran,
W. Abida,
R. Bradley,
J. Vinson,
Xuhong Cao,
...
Pankaj Vats,
L. Kunju,
M. Hussain,
F. Feng,
S. Tomlins,
K. Cooney,
David C. Smith,
Christine A Brennan,
J. Siddiqui,
R. Mehra,
Yu Chen,
D. Rathkopf,
M. Morris,
S. Solomon,
J. Durack,
V. Reuter,
A. Gopalan,
Jianjiong Gao,
M. Loda,
R. Lis,
M. Bowden,
S. Balk,
Glenn C. Gaviola,
C. Sougnez,
Manaswi Gupta,
E. Yu,
E. Mostaghel,
Heather H. Cheng,
Hyojeong Mulcahy,
L. True,
S. Plymate,
H. Dvinge,
R. Ferraldeschi,
P. Flohr,
S. Miranda,
Z. Zafeiriou,
N. Tunariu,
J. Mateo,
R. Pérez-López,
F. Demichelis,
B. Robinson,
M. Schiffman,
D. Nanus,
S. Tagawa,
Alexandros Sigaras,
Kenneth Eng,
O. Elemento,
A. Sboner,
E. Heath,
H. Scher,
K. Pienta,
P. Kantoff,
J. Bono,
M. Rubin,
P. Nelson,
L. Garraway,
C. Sawyers,
A. Chinnaiyan
|
11 |
2015 |
11
🐜
|
|
🐜
|
The polycomb group protein EZH2 is involved in progression of prostate cancer
12 auth.
S. Varambally,
S. Dhanasekaran,
Ming Zhou,
T. Barrette,
Chandan Kumar-Sinha,
M. Sanda,
...
D. Ghosh,
K. Pienta,
R. Sewalt,
A. Otte,
M. Rubin,
A. Chinnaiyan
|
11 |
2002 |
11
🐜
|
|
🐜
|
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
16 auth.
S. Tomlins,
D. Rhodes,
S. Perner,
S. Dhanasekaran,
R. Mehra,
Xiao-wei Sun,
S. Varambally,
Xuhong Cao,
J. Tchinda,
R. Kuefer,
...
Charles Lee,
J. Montie,
R. Shah,
K. Pienta,
M. Rubin,
A. Chinnaiyan
|
11 |
2006 |
11
🐜
|
|
🐜
|
The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer
27 auth.
C. Grasso,
Yi-Mi Wu,
D. Robinson,
Xuhong Cao,
S. Dhanasekaran,
Amjad P. Khan,
M. Quist,
Xiaojun Jing,
R. Lonigro,
J. Brenner,
I. Asangani,
Bushra Ateeq,
S. Chun,
J. Siddiqui,
L. Sam,
...
Matt Anstett,
R. Mehra,
John R. Prensner,
N. Palanisamy,
Gregory A. Ryslik,
Fabio Vandin,
Benjamin J. Raphael,
L. Kunju,
D. Rhodes,
K. Pienta,
A. Chinnaiyan,
S. Tomlins
|
11 |
2012 |
11
🐜
|
|
🐜
|
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
10 auth.
J. D. de Bono,
H. Scher,
R. Montgomery,
C. Parker,
M. Miller,
H. Tissing,
...
G. Doyle,
L. Terstappen,
K. Pienta,
D. Raghavan
|
10 |
2008 |
10
🐜
|
|
🐜
|
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
16 auth.
S. Tomlins,
D. Rhodes,
S. Perner,
S. Dhanasekaran,
R. Mehra,
Xiao-wei Sun,
S. Varambally,
Xuhong Cao,
J. Tchinda,
R. Kuefer,
...
Charles Lee,
J. Montie,
R. Shah,
K. Pienta,
M. Rubin,
A. Chinnaiyan
|
10 |
2005 |
10
🐜
|
|
🐜
|
Delineation of prognostic biomarkers in prostate cancer
9 auth.
S. Dhanasekaran,
T. Barrette,
D. Ghosh,
R. Shah,
S. Varambally,
K. Kurachi,
...
K. Pienta,
M. Rubin,
A. Chinnaiyan
|
10 |
2001 |
10
🐜
|
|
🐜
|
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
25 auth.
D. Robinson,
Yi-Mi Wu,
Pankaj Vats,
Fengyun Su,
R. Lonigro,
Xuhong Cao,
Shanker Kalyana-Sundaram,
Rui Wang,
Yu Ning,
L. Hodges,
Amy Gursky,
J. Siddiqui,
S. Tomlins,
S. Roychowdhury,
K. Pienta,
...
Scott Y. H. Kim,
J. Roberts,
J. Rae,
C. V. Van Poznak,
D. Hayes,
R. Chugh,
L. Kunju,
M. Talpaz,
A. Schott,
A. Chinnaiyan
|
9 |
2013 |
9
🐜
|
|
🐬
|
Prostate Cancer Metastasis to Bone Use of the Stromal Cell-derived Factor-1 / CXCR 4 Pathway in Updated Version
R. Taichman,
C. Cooper,
E. Keller,
K. Pienta,
N. Taichman,
L. McCauley
|
9 |
2002 |
9
🐬
|
|
🐜
|
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
20 auth.
S. Tomlins,
B. Laxman,
S. Dhanasekaran,
Beth E. Helgeson,
Xuhong Cao,
David S. Morris,
A. Menon,
Xiaojun Jing,
Q. Cao,
B. Han,
...
Jindan Yu,
L. Wang,
J. Montie,
M. Rubin,
K. Pienta,
D. Roulston,
R. Shah,
S. Varambally,
R. Mehra,
A. Chinnaiyan
|
9 |
2007 |
9
🐜
|
|
🐜
|
Integrative molecular concept modeling of prostate cancer progression
12 auth.
S. Tomlins,
R. Mehra,
D. Rhodes,
Xuhong Cao,
L. Wang,
S. Dhanasekaran,
...
Shanker Kalyana-Sundaram,
John T. Wei,
M. Rubin,
K. Pienta,
R. Shah,
A. Chinnaiyan
|
9 |
2007 |
9
🐜
|
|
🐜
|
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
26 auth.
R. Phillips,
W. Shi,
M. Deek,
N. Radwan,
S. Lim,
E. Antonarakis,
S. Rowe,
A. Ross,
M. Gorin,
C. Deville,
S. Greco,
Hailun Wang,
S. Denmeade,
C. Paller,
S. Dipasquale,
...
T. DeWeese,
D. Song,
Hao Wang,
M. Carducci,
K. Pienta,
M. Pomper,
A. Dicker,
M. Eisenberger,
Ash A. Alizadeh,
M. Diehn,
P. Tran
|
9 |
2020 |
9
🐜
|
|
🐜
|
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.
15 auth.
S. Varambally,
Jianjun Yu,
B. Laxman,
D. Rhodes,
R. Mehra,
S. Tomlins,
R. Shah,
U. Chandran,
F. Monzon,
M. Becich,
...
John T. Wei,
K. Pienta,
D. Ghosh,
M. Rubin,
A. Chinnaiyan
|
9 |
2005 |
9
🐜
|
|
🐢
|
Targeting the tumour stroma to improve cancer therapy
K. Valkenburg,
Amber E. de Groot,
K. Pienta
|
9 |
2018 |
9
🐢
|
